Larotrectinib - Bayer/Loxo Oncology
At a glance
- Drug Originator Array BioPharma
- Drug Licenced by Bayer; Loxo Oncology
- Drug Class Amides; Antineoplastics; Fluorobenzenes; Pyrazoles; Pyrimidines; Pyrrolidines; Small molecules; Tumour-agnostic therapies
- Mechanism of Action TrkA receptor antagonists; TrkB receptor antagonists; TrkC receptor antagonists
- USA Patent Applicants BAYER HLTHCARE; BAYER HEALTHCARE
- USA Patents 20
- NDAs 2
- International Patents 209
- Patent Applications 210
Table of Contents

Disclaimer